Using human isogenic PARK2−/− induced pluripotent stem cell-derived neurons, researchers report the formation of seeding-competent α-synuclein aggregates; Challenging the view of PARK2-related #Parkinsons as a non-synucleinopathy
https://t.co/EPD5qZKTgx
I'm happy to share our new publication on formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons.
#Parkinsons
https://t.co/PON6NC6rmd
@LabMorten
It has been absolutely fantastic to join the @WadeMartinsLab at @KavliOxford for the last half year. What a great scientific environment and talented people. Grateful for your amazing supervision @BRyanLab2!
Sad to say goodbye to @SisselSchmidt1 after 6 months of awesomeness with us working on PRKN and GBA iPSCs. We hope you enjoyed your time in @WadeMartinsLab@KavliOxford and wish you the best of luck finishing your PhD with @LabMorten 🥲
New review from our group is out in @Cells_MDPI discussing the interaction between Parkin and a-synuclein in PARK2-mediated #Parkinsons
https://t.co/LcGcY8NbyU
@LabMorten @SUND_SDU
Our new paper is out in @stemcellreports showing that #microglia can enhance dopaminergic differentiation of neural stem cells through secreted factors including TNFa and IL-1b
https://t.co/AlFAl8mPRb
@LabMorten @SUND_SDU
Meyer group strategy meeting today: planning ongoing and future #Parkinsons research projects with these lovely people. Check out the group here https://t.co/s9llrDYuaM @SUND_SDU